E-LIB Suche - Ergebnisse für: Fries,, Walter

1

Safety and effectiveness of tofacitinib in ulcerative colit..:

Macaluso, Fabio Salvatore ; D'Antonio, Elvira ; Fries, Walter...
Digestive and Liver Disease. 56 (2024) 1 - p. 15-20 , 2024

Link: https://doi.org/10.1016/..

2

Pragmatic Trial Design to Compare Real-world Effectiveness ..:

Fantini, Massimo Claudio ; Fiorino, Gionata ; Colli, Agostino...
Journal of Crohn's and Colitis. , 2024

Link: https://doi.org/10.1093/..

3

Follow-up evaluation and management of anemia in inflammato..:

Bergamaschi, Gaetano ; Castiglione, Fabiana ; D'Incà, Renata...
Digestive and Liver Disease. , 2024

Link: https://doi.org/10.1016/..

4

Transition care in patients with IBD: The pediatric and the..:

Castiglione, Fabiana ; Scarallo, Luca ; Nardone, Olga Maria...
Digestive and Liver Disease. 56 (2024) 5 - p. 802-809 , 2024

Link: https://doi.org/10.1016/..

5

Tu1819 REAL-LIFE EFFECTIVENESS AND SAFETY OF TOFACITINIB AN..:

Noviello, Daniele ; Savarino, Edoardo V. ; Fries, Walter...
Gastroenterology. 166 (2024) 5 - p. S-1421 , 2024

Link: https://doi.org/10.1016/..

6

Timing of proper introduction, optimization and maintenance..:

Ardizzone, Sandro ; Armuzzi, Alessandro ; Caprioli, Flavio...
Digestive and Liver Disease. 56 (2024) 1 - p. 98-105 , 2024

Link: https://doi.org/10.1016/..

7

Efficacy and Safety of Biological Therapies and JAK Inhibit..:

Fries, Walter ; Basile, Giorgio ; Bellone, Federica..
Cells. 12 (2023) 13 - p. 1722 , 2023

Link: https://doi.org/10.3390/..

8

Quality of Life (QoL) in Patients with Chronic Inflammatory..:

Bellone, Federica ; Morace, Carmela ; Impalà, Giulia...
Journal of Personalized Medicine. 13 (2023) 6 - p. 947 , 2023

Link: https://doi.org/10.3390/..

9

Mitigating the Risk of Tofacitinib-induced Adverse Events i..:

Viola, Anna ; Li Voti, Raffaele ; Bivacqua, Chiara...
Journal of Crohn's and Colitis. 18 (2023) 3 - p. 488-491 , 2023

Link: https://doi.org/10.1093/..

10

The effectiveness of ustekinumab and vedolizumab as third-l..:

Macaluso, Fabio Salvatore ; Grova, Mauro ; Saladino, Marica...
Digestive and Liver Disease. 55 (2023) 4 - p. 471-477 , 2023

Link: https://doi.org/10.1016/..

11

Ustekinumab is a promising option for the treatment of post..:

Macaluso, Fabio Salvatore ; Grova, Mauro ; Mocciaro, Filippo...
Journal of Gastroenterology and Hepatology. 38 (2023) 9 - p. 1503-1509 , 2023

Link: https://doi.org/10.1111/..

12

Low Adherence is Associated with Chronic Active Disease in ..:

Viola, Anna ; Demarzo, Maria Giulia ; Abbruzzese, Alfredo...
Patient Preference and Adherence. 17 (2023) - p. 807-816 , 2023

Link: https://doi.org/10.2147/..

13

An Objective Comparison of Vedolizumab and Ustekinumab Effe..:

Onali, Sara ; Pugliese, Daniela ; Caprioli, Flavio Andrea...
American Journal of Gastroenterology. 117 (2022) 8 - p. 1279-1287 , 2022

Link: https://doi.org/10.14309..

14

Alterations of Serum Bile Acid Profile in Patients with Cro..:

Sun, Rui ; Jiang, Jingjing ; Yang, Ling...
Gastroenterology Research and Practice. 2022 (2022) - p. 1-9 , 2022

Link: https://doi.org/10.1155/..

15

Risk Factors for Worsening of Bone Loss in Patients Newly D..:

Yin, Yi ; Lu, Xiaofeng ; Li, Zhun...
Gastroenterology Research and Practice. 2022 (2022) - p. 1-10 , 2022

Link: https://doi.org/10.1155/..